Advertisement #1
Home Authors Posts by Joe Woolery, B.S., Pharm.D., BCOP

Joe Woolery, B.S., Pharm.D., BCOP

Joe Woolery, B.S., Pharm.D., BCOP joined Zymeworks in September 2019 and currently serves as our Executive Director of Early-Stage Development in the Americas and Global Lead for zanidatamab zovodotin (ZW49). Woolery previously held positions at Seagen working on registrational studies with Adcetris in Peripheral T-Cell Lymphoma and Tukysa in HER2+ Metastatic Breast Cancer. Prior to transitioning to the pharmaceutical industry, Woolery practiced as a Clinical Oncology Pharmacist at the University of Texas M.D. Anderson and Banner M.D. Anderson Cancer Centers. Woolery received a PharmD from the University of Missouri-Kansas City. He also completed residency’s in clinical pharmacy practice at The University of Arizona and oncology fellowship at H. Lee Moffitt Cancer Center and Research Institute. Dr. Woolery is a board-certified oncology pharmacist and a member of the American Society of Clinical Oncology and the European Society of Medical Oncology.